Sumary of Largest U.S. study shares first results on effects of COVID-19 on cancer patients:
- These findings were shared in an oral presentation June 4 at the annual meeting of the American Society of Clinical Oncology by University of Alabama at Birmingham Assistant Professor Noha Sharafeldin, MBBCh, Ph.D..
- Sharafeldin is a medical doctor and epidemiologist in the Division of Hematology and Oncology and member of UAB’s Institute for Cancer Outcomes and Survivorship and the O’Neal Comprehensive Cancer Center..
- UAB and 54 other clinical institutions nationwide have contributed de-identified electronic health record data from 6.2 million patients from 49 states to a secure, cloud-based database to enable first-of-its-kind research..
- “The N3C contains a huge amount of data that has allowed us to investigate these questions at a scale that has not been possible before, using real-world clinical data,”.
- From its founding, N3C leadership has encouraged researchers interested in COVID-19’s effects on particular health conditions to form clinical domain teams..
- Along with Umit Topaloglu, Ph.D., an informatician from Wake Forest University, and Benjamin Bates, M.D., a clinician at Rutgers University, Sharafeldin is co-leading the N3C Oncology Domain Team..
- “We started by simply investigating the feasibility of answering these questions we had about COVID’s effects on patients with cancer using N3C’s data resources,”.
- “As we went along, the oncology domain team started expanding to include biostatisticians, bioinformatics and analysis experts, and researchers in machine learning and other advanced applications, as well as clinicians -;…